U.S. flag

An official website of the United States government

NM_001348800.3(ZBTB20):c.1805G>A (p.Gly602Asp) AND Primrose syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jul 1, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000845023.2

Allele description [Variation Report for NM_001348800.3(ZBTB20):c.1805G>A (p.Gly602Asp)]

NM_001348800.3(ZBTB20):c.1805G>A (p.Gly602Asp)

Gene:
ZBTB20:zinc finger and BTB domain containing 20 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q13.31
Genomic location:
Preferred name:
NM_001348800.3(ZBTB20):c.1805G>A (p.Gly602Asp)
HGVS:
  • NC_000003.12:g.114339426C>T
  • NG_052992.1:g.812855G>A
  • NM_001164342.2:c.1805G>A
  • NM_001164343.2:c.1586G>A
  • NM_001164344.4:c.1586G>A
  • NM_001164345.4:c.1586G>A
  • NM_001164346.2:c.1586G>A
  • NM_001164347.2:c.1586G>A
  • NM_001348800.3:c.1805G>AMANE SELECT
  • NM_001348801.3:c.1586G>A
  • NM_001348802.3:c.1586G>A
  • NM_001348803.3:c.1805G>A
  • NM_001348804.3:c.1586G>A
  • NM_001348805.3:c.1586G>A
  • NM_001393393.1:c.1805G>A
  • NM_001393394.1:c.1805G>A
  • NM_001393395.1:c.1586G>A
  • NM_001393396.1:c.1586G>A
  • NM_015642.7:c.1586G>A
  • NP_001157814.1:p.Gly602Asp
  • NP_001157815.1:p.Gly529Asp
  • NP_001157816.1:p.Gly529Asp
  • NP_001157817.1:p.Gly529Asp
  • NP_001157818.1:p.Gly529Asp
  • NP_001157819.1:p.Gly529Asp
  • NP_001335729.1:p.Gly602Asp
  • NP_001335730.1:p.Gly529Asp
  • NP_001335731.1:p.Gly529Asp
  • NP_001335732.1:p.Gly602Asp
  • NP_001335733.1:p.Gly529Asp
  • NP_001335734.1:p.Gly529Asp
  • NP_001380322.1:p.Gly602Asp
  • NP_001380323.1:p.Gly602Asp
  • NP_001380324.1:p.Gly529Asp
  • NP_001380325.1:p.Gly529Asp
  • NP_056457.3:p.Gly529Asp
  • NC_000003.11:g.114058273C>T
  • NR_121662.3:n.470G>A
Protein change:
G529D
Links:
dbSNP: rs483353068
NCBI 1000 Genomes Browser:
rs483353068
Molecular consequence:
  • NM_001164342.2:c.1805G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001164343.2:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001164344.4:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001164345.4:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001164346.2:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001164347.2:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348800.3:c.1805G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348801.3:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348802.3:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348803.3:c.1805G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348804.3:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348805.3:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393393.1:c.1805G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393394.1:c.1805G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393395.1:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001393396.1:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_015642.7:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_121662.3:n.470G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Primrose syndrome
Synonyms:
Ossified ear cartilages with mental deficiency, muscle wasting, and bony changes; Intellectual disability-cataracts-calcified pinnae-myopathy syndrome
Identifiers:
MONDO: MONDO:0009798; MedGen: C0796121; OMIM: 259050

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000986856GenomeConnect, ClinGen
no classification provided
not providedde novophenotyping only

SCV004171007DECIPHERD-UDD, Universidad del Desarrollo
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jul 1, 2023)
de novoresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyesnot providednot providednot providednot providednot providedresearch, phenotyping only

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Decoding complex inherited phenotypes in rare disorders: the DECIPHERD initiative for rare undiagnosed diseases in Chile.

Poli MC, Rebolledo-Jaramillo B, Lagos C, Orellana J, Moreno G, Martín LM, Encina G, Böhme D, Faundes V, Zavala MJ, Hasbún T, Fischer S, Brito F, Araya D, Lira M, de la Cruz J, Astudillo C, Lay-Son G, Cares C, Aracena M, Martin ES, Coban-Akdemir Z, et al.

Eur J Hum Genet. 2024 Jan 4. doi: 10.1038/s41431-023-01523-5. [Epub ahead of print]

PubMed [citation]
PMID:
38177409

Details of each submission

From GenomeConnect, ClinGen, SCV000986856.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedphenotyping onlynot provided

Description

Variant interpretted as Likely pathogenic and reported on 07/11/2018 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providedvalidationnot providednot providednot providednot provided

From DECIPHERD-UDD, Universidad del Desarrollo, SCV004171007.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 10, 2024